NHS soup and shake diet can beat type 2 diabetes
The NHS has launched a 900-calorie liquid diet program to reverse type 2 diabetes, offering significant weight loss and remission support, fully funded and available across England for eligible participants.
Read original article
A new NHS program offers a 900-calorie-a-day liquid diet consisting of soups, shakes, and meal-replacement bars to help individuals reverse type 2 diabetes. Research published in The Lancet Diabetes & Endocrinology journal indicates that participants who adhered to the program for a year experienced significant weight loss, with one-third losing nearly 16 kg and achieving diabetes remission. The program is available across England and is fully funded by the NHS, providing personalized diet and exercise advice along with support from healthcare professionals. Eligibility criteria include being aged 18 to 65, diagnosed with type 2 diabetes within the last six years, and having a BMI over 27 (or over 25 for certain ethnic groups). Participants report positive experiences, noting improvements in their health and lifestyle. Experts emphasize the importance of weight loss in managing diabetes and highlight the potential long-term benefits of the program, although the duration of remission remains uncertain. The initiative aims to address obesity, a significant health challenge in the UK, and its associated risks.
- The NHS offers a 900-calorie liquid diet to help reverse type 2 diabetes.
- Participants can lose significant weight and achieve diabetes remission.
- The program is fully funded by the NHS and includes personalized support.
- Eligibility includes age, recent diabetes diagnosis, and BMI criteria.
- Weight loss is crucial for managing diabetes and improving overall health.
Related
A 5,2 Intermittent Fasting Meal Replacement Diet for Adults with Diabetes
A randomized trial compared 5:2 intermittent fasting with metformin and empagliflozin in diabetic adults. Results showed improved glycemic control with reduced HbA1c levels and fasting glucose, suggesting potential benefits for diabetes management.
'Skinny jabs': weight-loss drugs set for new boom as generic versions emerge
Medicines like Wegovy and Saxenda, known as "skinny jabs," are gaining popularity for weight loss. Generic versions, like Teva's generic Victoza, are expected to increase accessibility and affordability, benefiting a broader population. Novo Nordisk invests $4 billion to meet rising demand.
The Calorie-Restriction Experiment (2009)
The Calorie-Restriction Experiment (Calerie) studies the effects of a 25% caloric intake reduction on aging and diseases in 132 participants, showing potential benefits for cardiovascular health and cancer risk.
Microwave technology saves diabetic patient from double amputation
Barry Mayled, a 74-year-old diabetic, avoided double leg amputation through the Swift microwave treatment, which healed his foot ulcers. This advancement highlights the potential of innovative diabetic care technologies.
NHS 'soup and shake' diet puts almost 1/3 of type 2 diabetes cases in remission
A study found that the NHS's "soup and shake" diet helped nearly one-third of type 2 diabetes participants achieve remission, with plans to expand the program to 50,000 participants.
3 commentsI cannot find the actual recipes. Are they available somewhere?
Related
A 5,2 Intermittent Fasting Meal Replacement Diet for Adults with Diabetes
A randomized trial compared 5:2 intermittent fasting with metformin and empagliflozin in diabetic adults. Results showed improved glycemic control with reduced HbA1c levels and fasting glucose, suggesting potential benefits for diabetes management.
'Skinny jabs': weight-loss drugs set for new boom as generic versions emerge
Medicines like Wegovy and Saxenda, known as "skinny jabs," are gaining popularity for weight loss. Generic versions, like Teva's generic Victoza, are expected to increase accessibility and affordability, benefiting a broader population. Novo Nordisk invests $4 billion to meet rising demand.
The Calorie-Restriction Experiment (2009)
The Calorie-Restriction Experiment (Calerie) studies the effects of a 25% caloric intake reduction on aging and diseases in 132 participants, showing potential benefits for cardiovascular health and cancer risk.
Microwave technology saves diabetic patient from double amputation
Barry Mayled, a 74-year-old diabetic, avoided double leg amputation through the Swift microwave treatment, which healed his foot ulcers. This advancement highlights the potential of innovative diabetic care technologies.
NHS 'soup and shake' diet puts almost 1/3 of type 2 diabetes cases in remission
A study found that the NHS's "soup and shake" diet helped nearly one-third of type 2 diabetes participants achieve remission, with plans to expand the program to 50,000 participants.